2021 annual financial data
Adaptive Biotechnologies 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -124.87%.
Operating income was -208,966,000 USD and net income was -207,279,000 USD.
Operating cash flow was -192,727,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,344,000 USD
- Operating income
- -208,966,000 USD
- Net income
- -207,279,000 USD
- Operating cash flow
- -192,727,000 USD